Staar Surgical Co. today announced that the shareholder vote to determine if the Alcon deal moves forward was postponed until Nov. 6.
The meeting, originally scheduled for today, was adjourned with no other business being conducted, the company said.
The company has been facing pushback from its largest shareholder, Broadwood Partners, which yesterday announced its intent to call a special meeting to remove several board directors in an attempt to prevent a delayed vote.
Shares in Staar rose 4% to $25.92 and a market cap of $1.3 billion following the announcement.
